Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression

Charles Nemeroff, D. L. Knight, K. R R Krishnan, T. A. Slotkin, G. Bissette, M. L. Melville, D. G. Blazer

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The number (B(max)) and affinity (K(d)) of platelet-tritiated imipramine binding sites was determined in young and middle-aged controls 50 years of age and younger (n = 25), elderly normal controls over 60 years of age (n = 18), patients who fulfilled DSM-III criteria for major depression who were under 50 years of age (n = 29), patients who fulfilled DSM-III criteria for major depression who were 60 years of age and older (n = 19), and patients who fulfilled both DSM-III criteria for primary degenerative dementia and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer's disease (n = 13). Both groups of depressed patients (under 50 and over 60 years of age) exhibited significant reductions (↓ 42%) in the number of platelet-tritiated imipramine binding sites with no change in affinity, when compared with their age-matched controls. There was little overlap in B(max) values between the elderly depressed patients and their controls. The patients with probable Alzheimer's disease showed no alteration in platelet-tritiated imipramine binding. There was no statistically significant relationship between postdexamethasone plasma cortisol concentrations and tritiated imipramine binding. These results indicate that platelet-tritiated imipramine binding may have potential utility as a diagnostic adjunct in geriatric depression, and moreover that the reduction in the number of platelet-tritiated imipramine binding sites is not due to hypercortisolemia.

Original languageEnglish
Pages (from-to)919-923
Number of pages5
JournalArchives of General Psychiatry
Volume45
Issue number10
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Imipramine
Platelet Count
Geriatrics
Binding Sites
Depression
Diagnostic and Statistical Manual of Mental Disorders
Blood Platelets
Alzheimer Disease
National Institute of Neurological Disorders and Stroke
Communication Disorders
Dementia
Hydrocortisone

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Nemeroff, C., Knight, D. L., Krishnan, K. R. R., Slotkin, T. A., Bissette, G., Melville, M. L., & Blazer, D. G. (1988). Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Archives of General Psychiatry, 45(10), 919-923.

Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. / Nemeroff, Charles; Knight, D. L.; Krishnan, K. R R; Slotkin, T. A.; Bissette, G.; Melville, M. L.; Blazer, D. G.

In: Archives of General Psychiatry, Vol. 45, No. 10, 01.01.1988, p. 919-923.

Research output: Contribution to journalArticle

Nemeroff, C, Knight, DL, Krishnan, KRR, Slotkin, TA, Bissette, G, Melville, ML & Blazer, DG 1988, 'Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression', Archives of General Psychiatry, vol. 45, no. 10, pp. 919-923.
Nemeroff C, Knight DL, Krishnan KRR, Slotkin TA, Bissette G, Melville ML et al. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Archives of General Psychiatry. 1988 Jan 1;45(10):919-923.
Nemeroff, Charles ; Knight, D. L. ; Krishnan, K. R R ; Slotkin, T. A. ; Bissette, G. ; Melville, M. L. ; Blazer, D. G. / Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. In: Archives of General Psychiatry. 1988 ; Vol. 45, No. 10. pp. 919-923.
@article{788e6e7f653843929cd387048d76b8b9,
title = "Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression",
abstract = "The number (B(max)) and affinity (K(d)) of platelet-tritiated imipramine binding sites was determined in young and middle-aged controls 50 years of age and younger (n = 25), elderly normal controls over 60 years of age (n = 18), patients who fulfilled DSM-III criteria for major depression who were under 50 years of age (n = 29), patients who fulfilled DSM-III criteria for major depression who were 60 years of age and older (n = 19), and patients who fulfilled both DSM-III criteria for primary degenerative dementia and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer's disease (n = 13). Both groups of depressed patients (under 50 and over 60 years of age) exhibited significant reductions (↓ 42{\%}) in the number of platelet-tritiated imipramine binding sites with no change in affinity, when compared with their age-matched controls. There was little overlap in B(max) values between the elderly depressed patients and their controls. The patients with probable Alzheimer's disease showed no alteration in platelet-tritiated imipramine binding. There was no statistically significant relationship between postdexamethasone plasma cortisol concentrations and tritiated imipramine binding. These results indicate that platelet-tritiated imipramine binding may have potential utility as a diagnostic adjunct in geriatric depression, and moreover that the reduction in the number of platelet-tritiated imipramine binding sites is not due to hypercortisolemia.",
author = "Charles Nemeroff and Knight, {D. L.} and Krishnan, {K. R R} and Slotkin, {T. A.} and G. Bissette and Melville, {M. L.} and Blazer, {D. G.}",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "45",
pages = "919--923",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression

AU - Nemeroff, Charles

AU - Knight, D. L.

AU - Krishnan, K. R R

AU - Slotkin, T. A.

AU - Bissette, G.

AU - Melville, M. L.

AU - Blazer, D. G.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The number (B(max)) and affinity (K(d)) of platelet-tritiated imipramine binding sites was determined in young and middle-aged controls 50 years of age and younger (n = 25), elderly normal controls over 60 years of age (n = 18), patients who fulfilled DSM-III criteria for major depression who were under 50 years of age (n = 29), patients who fulfilled DSM-III criteria for major depression who were 60 years of age and older (n = 19), and patients who fulfilled both DSM-III criteria for primary degenerative dementia and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer's disease (n = 13). Both groups of depressed patients (under 50 and over 60 years of age) exhibited significant reductions (↓ 42%) in the number of platelet-tritiated imipramine binding sites with no change in affinity, when compared with their age-matched controls. There was little overlap in B(max) values between the elderly depressed patients and their controls. The patients with probable Alzheimer's disease showed no alteration in platelet-tritiated imipramine binding. There was no statistically significant relationship between postdexamethasone plasma cortisol concentrations and tritiated imipramine binding. These results indicate that platelet-tritiated imipramine binding may have potential utility as a diagnostic adjunct in geriatric depression, and moreover that the reduction in the number of platelet-tritiated imipramine binding sites is not due to hypercortisolemia.

AB - The number (B(max)) and affinity (K(d)) of platelet-tritiated imipramine binding sites was determined in young and middle-aged controls 50 years of age and younger (n = 25), elderly normal controls over 60 years of age (n = 18), patients who fulfilled DSM-III criteria for major depression who were under 50 years of age (n = 29), patients who fulfilled DSM-III criteria for major depression who were 60 years of age and older (n = 19), and patients who fulfilled both DSM-III criteria for primary degenerative dementia and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer's disease (n = 13). Both groups of depressed patients (under 50 and over 60 years of age) exhibited significant reductions (↓ 42%) in the number of platelet-tritiated imipramine binding sites with no change in affinity, when compared with their age-matched controls. There was little overlap in B(max) values between the elderly depressed patients and their controls. The patients with probable Alzheimer's disease showed no alteration in platelet-tritiated imipramine binding. There was no statistically significant relationship between postdexamethasone plasma cortisol concentrations and tritiated imipramine binding. These results indicate that platelet-tritiated imipramine binding may have potential utility as a diagnostic adjunct in geriatric depression, and moreover that the reduction in the number of platelet-tritiated imipramine binding sites is not due to hypercortisolemia.

UR - http://www.scopus.com/inward/record.url?scp=0023737084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023737084&partnerID=8YFLogxK

M3 - Article

C2 - 2844132

AN - SCOPUS:0023737084

VL - 45

SP - 919

EP - 923

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 10

ER -